Literature DB >> 23843761

Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia: a case report.

Jorge H Villafañe1, Cesar Fernandez-de-Las-Peñas, Paolo Pillastrini.   

Abstract

OBJECTIVE: The purpose of this case study is to present the findings of combining botulinum toxin type A (BoNT-A) and cervical spine manual therapy to address masseter muscle spasticity in a patient with Alzheimer-type dementia. CASE REPORT: A 78-year-old woman with bilateral spasticity of the masseteric regions for 2 years was referred for physiotherapy. She had trismus and bruxism, and could neither close nor open her mouth normally; thus, she was unable to be fed orally in a normal manner. INTERVENTION AND OUTCOME: The patient underwent combined treatment with BoNT-A and cervical spine manual therapy. A medical physician (neurologist) performed the BoNT-A injections into 2 points at the center of the lower third of the masseter muscle. A physical therapist performed manual therapy interventions targeted at the cervical spine. Manual therapy started the day after the BoNT-A injection and continued for 5 sessions per week for a total period of 2 weeks. Clinical outcomes were measured including spasticity (Modified Ashworth Scale), functionality (Barthel Index), and jaw opening. Outcomes were conducted at baseline, 2 weeks after treatment, and at 2-month follow-up session after finishing the treatment. The patient improved in all of the outcomes at the end of treatment, and these results were maintained during the follow-up. After treatment, the patient was able to feed with minimal caregiver dependency because oral feeding was possible.
CONCLUSION: The patient in this study responded positively to a combination of BoNT-A and manual therapy, resulting in decreased masseter muscles spasticity and improved trismus and bruxism.

Entities:  

Keywords:  Alzheimer disease; Botulinum toxin type A; Masseter muscle, cervical spine; Muscle spasticity; Physiotherapy; Stroke

Year:  2012        PMID: 23843761      PMCID: PMC3706701          DOI: 10.1016/j.jcm.2012.10.004

Source DB:  PubMed          Journal:  J Chiropr Med        ISSN: 1556-3707


  33 in total

Review 1.  Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature.

Authors:  T Platz; C Eickhof; G Nuyens; P Vuadens
Journal:  Disabil Rehabil       Date:  2005 Jan 7-21       Impact factor: 3.033

2.  Masseter muscle reduction procedure with radiofrequency coagulation.

Authors:  Jong-Wook Ham
Journal:  J Oral Maxillofac Surg       Date:  2009-02       Impact factor: 1.895

3.  Treatment of bruxism with botulinum toxin injections.

Authors:  M Van Zandijcke; M M Marchau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

4.  Symptomatic upper limb spasticity in patients with chronic stroke attending a rehabilitation clinic: frequency, clinical correlates and predictors.

Authors:  Keng-He Kong; Karen Sui-Geok Chua; Jeanette Lee
Journal:  J Rehabil Med       Date:  2010-05       Impact factor: 2.912

5.  Time-course and determinants of spasticity during the first six months following first-ever stroke.

Authors:  Erik Lundström; Anja Smits; Andreas Terént; Jörgen Borg
Journal:  J Rehabil Med       Date:  2010-04       Impact factor: 2.912

6.  Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report.

Authors:  Andrea Santamato; Francesco Panza; Daniela Di Venere; Vincenzo Solfrizzi; Vincenza Frisardi; Maurizio Ranieri; Pietro Fiore
Journal:  J Chiropr Med       Date:  2010-09

7.  Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.

Authors:  Allison Brashear; Mark F Gordon; Elie Elovic; V Daniel Kassicieh; Christina Marciniak; Mai Do; Chia-Ho Lee; Stephen Jenkins; Catherine Turkel
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

8.  Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.

Authors:  Elizabeth Cousins; Anthony B Ward; Christine Roffe; Lesley D Rimington; Anand D Pandyan
Journal:  Phys Ther       Date:  2009-05-29

Review 9.  Treatment of temporomandibular disorders with botulinum toxin.

Authors:  Marvin Schwartz; Brian Freund
Journal:  Clin J Pain       Date:  2002 Nov-Dec       Impact factor: 3.442

10.  Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Authors:  Helen Rodgers; Lisa Shaw; Christopher Price; Frederike van Wijck; Michael Barnes; Laura Graham; Gary Ford; Phil Shackley; Nick Steen
Journal:  Trials       Date:  2008-10-23       Impact factor: 2.279

View more
  3 in total

1.  Botulinum toxin type A combined with neurodynamic mobilization for lower limb spasticity: a case report.

Authors:  Jorge H Villafañe
Journal:  J Chiropr Med       Date:  2013-03

2.  Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.

Authors:  Hong Jiang; Yi Xiang; Xingyue Hu; Huaying Cai
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

3.  Global Postural Reeducation in patients with chronic nonspecific neck pain: cross-over analysis of a randomized controlled trial.

Authors:  Paolo Pillastrini; Federico Banchelli; Andrew Guccione; Emanuele Di Ciaccio; Francesco Saverio Violante; Monia Brugnettini; Carla Vanti
Journal:  Med Lav       Date:  2018-02-01       Impact factor: 1.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.